Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial
In brief
A randomised trial compared one injection of bone marrow aspirate concentrate (BMAC) with leukocyte-rich platelet-rich plasma (PRP) in mild to moderate knee osteoarthritis over about a year. Both groups improved in pain and function and neither was superior. The authors note PRP has stronger supporting evidence and that the lack of a control group may have influenced results.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial Authors: Adam W Anz, Ryan Hubbard, Nicole K Rendos, Peter A Everts, James R Andrews, Joshua G Hackel Link: https://pubmed.ncbi.nlm.nih.gov/32118081/ Year of Publication: 2020
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

